← All diseases Liver, kidneys and digestion

Liver cirrhosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Quality Evidence Only (112)Meta-analysis (33)Treatment guideline (8)Randomized trial (33)Systematic review (22)Phase 3 study (16)Clinical trial (635)Review article (465)Early study (phase 1 or 2) (8)Laboratory or animal research (168)Case report (153)Commentary or editorial (44)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications (2524)

• Novel Internet Advertising Approach to Raise Public Awareness About Metabolic Dysfunction-Associated Steatotic Liver Disease. (2026/06/20) ♡
• [Dietary serine supplementation inhibits the hepatic macrophage AKT/mTOR pathway and improves primary biliary cholangitis]. (2026/06/20) ♡
• The PERK-GADD45A axis is a key driver of hepatic stellate cell activation. (2026/06/19) ♡
• Hepatology e-consult responses generated by artificial intelligence demonstrate accuracy but require human oversight. (2026/06/19) ♡
• Effect of testosterone addition to nutrition and exercise on muscle mass in men with cirrhosis: the next trial. (2026/06/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive Review. (2026/06/19) ♡
• Very Low Energy Ketogenic Therapy Effects on Fibrosis-Dependent Metabolic Reprogramming: A Serum NMR Pilot Study. (2026/06/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Management of pregnancy and outcomes in a woman with mannose-6-phosphate isomerase deficiency (MPI-CDG). (2026/06/17) ♡
• Low 25(OH)Vitamin D levels are associated with nutritional risk and disease severity in outpatient individuals with advanced chronic liver disease. (2026/06/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Advances in the Study of Traditional Chinese Medicine in Reversing Hepatic Fibrosis Through the Regulation of Hepatic Stellate Cells Apoptosis Pathways. (2026/06/15) ♡
• Buyanghuanwu decoction (BYHWD) attenuates hepatic fibrosis in CCl(4)-induced mice by regulating bile acid metabolism through activating PPARα. (2026/06/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The current status and emerging trends in the application of precision nutrition for the comprehensive, lifecycle-based management of chronic liver diseases. (2026/06/12) ♡
• Therapeutic target exploration of Shugan Jianpi formula in liver fibrosis: an integrated lncRNA-mRNA co-expression network analysis. (2026/06/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Liver and Gallbladder Disease in Persons With Diabetes. (2026/06/01) ♡
• Impact of the need for dental extractions on oral health-related quality of life in patients with cirrhosis: A cross-sectional study. (2026/06/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation. (2026/06/01) ♡
• Assessment of sarcopenia in cirrhosis: A practical approach using thigh and psoas ultrasound, bioimpedance, and anthropometry. (2026/06/01) ♡
• Precise prevention of DEHP induced hepatic fibrosis: Early identifying high-risk populations, revealing key factors, and applying targeted intervention. (2026/06/01) ♡
• Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study. (2026/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Evaluation of Abnormal Liver Biochemical Test Results. (2026/06/01) ♡
• Jiangcaoxiang alleviates hepatic fibrosis through the Nrf2/GPX4 signaling pathway: Elucidated via integrated network pharmacology, multi-omics profiling, and experimental validation. (2026/06/01) ♡
• A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis. (2026/06/01) ♡
• Risk Factors Associated with Mortality for Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis. (2026/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hypothyroidism in Nonalcoholic Fatty Liver Disease. (2026/06/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Hepatoprotective evaluation of benzoylated emodin derivatives: Integrating bioinformatics and in vitro studies. (2026/06/01) ♡
• An integrated strategy for screening Q-markers and elucidating anti-fibrotic mechanisms of Ganoderma lucidum. (2026/05/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ashwagandha (Withania somnifera)-Associated Liver Injury: A Scoping Review of Clinical Characteristics and Safety Considerations. (2026/05/27) ♡
• Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells. (2026/05/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Adjuvant therapeutic effects and mechanisms of Yinchenhao decoction in obstructive jaundice: a narrative review. (2026/05/21) ♡
• Modulation of mRNA Expression of Biomarkers in the UPR-PERK Pathway by Ellagic Acid in Metabolic Dysfunction-Associated Fatty Liver Disease. (2026/05/17) ♡
• Integrating Network Pharmacology and Experimental Validation to Elucidate the Role of Huaier in Attenuating Liver Fibrosis via the AKT Signalling Pathway. (2026/05/15) ♡
• Assessment of GALAD score as a diagnostic and prognostic factor of de novo hepatitis C-related hepatocellular carcinoma post treatment with direct-acting antivirals. (2026/05/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Occult cirrhosis presenting as progressive tremor: acquired hepatocerebral degeneration induced by traditional Chinese medicine and natural health products, aggravated by manganese supplements: A case report. (2026/05/08) ♡
• Qijia Rougan Formula alleviates liver fibrosis by inhibiting NLRP3-mediated pyroptosis and regulating macrophage polarization. (2026/05/05) ♡
• The impact of genetic and environmental risk factors on adverse liver outcomes. (2026/05/01) ♡
• Animal Naming Test Can Identify Covert Hepatic Encephalopathy in Patients With Cirrhosis With Limited Influence From Age or Educational Level. (2026/05/01) ♡
• The mechanism of the water layer extract of Cichorium pumilum Jacq water extract in the treatment of Hepatic fibrosis was investigated using HPLC-MS/MS and network pharmacology. (2026/05/01) ♡
• [Anti-fibrotic effects of Prismatomeris tetrandra ethyl acetate fraction: chemical characterization, bioinformatics analysis, and in vivo validation]. (2026/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Peritonitis due to brucellosis in a patient newly diagnosed with liver cirrhosis complicated by ascites: A case report and literature review. (2026/04/28) ♡
• Empagliflozin versus dapagliflozin in patients with liver cirrhosis: A comparative real-world study on hepatic decompensation. (2026/04/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The therapeutic potential of botanicals: how medicinal plants targeting autophagy can reverse metabolic-associated fatty liver disease. (2026/04/07) ♡
• Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China. (2026/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Severity of liver disease is associated with cirrhotic cardiomyopathy: A multicenter study. (2026/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and management. (2026/04/01) ♡
• Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort. (2026/04/01) ♡
• MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD. (2026/04/01) ♡
• A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells. (2026/04/01) ♡
• Huang Qi Decoction inhibits differentiation of hepatic oval cells to cholangiocytes via the β-catenin pathway to ameliorate hepatic fibrosis. (2026/04/01) ♡
• Trichosanthes kirilowii extract alleviated liver fibrosis and acute myocardial infarction by inhibiting VCAN to restrain monocyte senescence: Insights from bioinformatic analyses and experimental validation. (2026/04/01) ♡
• Longchai Decoction Treated the Fibrosis of Liver Induced by CCl(4) Regulates Nrf2/GPX4 Pathway to Suppress Ferroptosis. (2026/04/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.